5-Bromoimidazo[1,2-a]pyrazine-2-carboxylic acid, 95%, 250mg

2-(2-Bromophenyl)-2-methylpropanenitrile, 95.0%, 5g

1-(5-Fluoropyridin-3-yl)-N-methylmethanamine, 95%, 500mg

4'-Methoxyacetophenone oxime, 97.0%, 25g

3-(5-(Trifluoromethyl)pyridin-2-yl)propanoic acid, 95.0%, 250mg

3-Methylpyrazin-2-ol, 95.0%, 10g

4-tert-Butylcyclohexyl Acetate (cis- and trans- mixture)>96.0%(GC)25mL

rel-4,4,5,5-Tetramethyl-2-[(1R,2S)-2-methylcyclopropyl]-1,3,2-dioxaborolane, 98%, 100mg

2-(5-Bromothiophen-2-yl)piperazine, 95+%, 100mg

(R)-1-(4-Bromophenyl)-ethylamine, 98.0%, 1g

Rac-(3r,4r)-1-[(tert-butoxy)carbonyl]pyrrolidine-3,4-dicarboxylic acid, 98%, 100mg

n-Butyl 2,2-difluorocyclopropanecarboxylate, 95.0%, 25g

Acetonitrile D3, 99.5 at%D, 10 ml, glass packaging